<DOC>
	<DOC>NCT00282256</DOC>
	<brief_summary>A study to assess the pharmacokinetics, safety and effectiveness of tacrolimus in stable pediatric liver transplant patients converted from a Prograf速 based immunosuppression regimen to a modified release tacrolimus based immunosuppression regimen.</brief_summary>
	<brief_title>A Study of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant Patients</brief_title>
	<detailed_description>A 1 arm study to assess the pharmacokinetics, and long-term safety and effectiveness of a modified release tacrolimus based immunosuppression regimen in stable pediatric liver transplant patients converted from a Prograf速 based immunosuppression regimen.</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Patient is currently receiving Prograf速 based immunosuppressive therapy for liver transplantation. Patient has stable whole blood trough level concentrations of Prograf速 and is clinically stable Patient has previously received an organ transplant other than a liver Patient is currently receiving sirolimus immunosuppression therapy.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Child</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Immunosuppression Drugs</keyword>
	<keyword>Hepatic transplant</keyword>
	<keyword>Liver Transplantation</keyword>
</DOC>